SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-23-099016
Filing Date
2023-09-07
Accepted
2023-09-07 17:46:47
Documents
2
Period of Report
2023-09-05

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2325674-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2325674-1_3seq1.xml 3 8753
2 EXHIBIT 24 tm2325674d1_ex24.htm EX-24 8864
  Complete submission text file 0001104659-23-099016.txt   19075
Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Issuer) CIK: 0001442836 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MERSANA THERAPEUTICS, INC. 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address
Bala Mohan (Reporting) CIK: 0001991787 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38129 | Film No.: 231243209